Author:
Glossop Melanie S.,Bazin Richard J.,Dack Kevin N.,Fox David N.A.,MacDonald Graeme A.,Mills Mark,Owen Dafydd R.,Phillips Chris,Reeves Keith A.,Ringer Tracy J.,Strang Ross S.,Watson Christine A.L.
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference16 articles.
1. Candoxatril, a neutral endopeptidase inhibitor
2. Formation and pharmacokinetics of the active drug candoxatrilat in mouse, rat, rabbit, dog and man following administration of the prodrug candoxatril
3. The endopeptidase inhibitor, candoxatril, and its therapeutic potential in the treatment of chronic cardiac failure in man
4. Vasopeptidase inhibitors: an emerging class of cardiovascular drugs
5. Pellacini, F.; Norcini, G.; Botta, D.; Romagnano, S.; Santangelo, F. WO 95/35307, 1995.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献